Literature DB >> 218027

The treatment of ACTH Paraneoplastic syndrome with aminoglutethimide.

C B Vaughn, S Pearson, J Chapman, B Chinn, D Banks.   

Abstract

A 60-year-old white female with oat-cell carcinoma of the lung presents with a recurrent pulmonary nodule and Cushing syndrome. The tumor is uncontrollable with MeCCNU and cyclophosphamide (Cytoxan), consequently the symptoms of Cushing disease become severe. Cushing syndrome is documented by laboratory examinations. Aminoglutethimide, an anticonvulsant, is used to reverse the symptomatology and also the laboratory values. When aminoglutethimide is discontinued, the laboratory findings return to pretreatment levels.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218027      PMCID: PMC2537248     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  12 in total

Review 1.  HORMONAL EFFECTS OF NONENDOCRINE TUMORS.

Authors:  B F BOWER; G S GORDAN
Journal:  Annu Rev Med       Date:  1965       Impact factor: 13.739

2.  Treatment of advanced malignancy and Cushing's syndrome with DDD.

Authors:  S WEISENFELD; M G GOLDNER
Journal:  Cancer Chemother Rep       Date:  1962-02

3.  Double isotope derivative assay of aldosterone in biological extracts.

Authors:  B KLIMAN; R E PETERSON
Journal:  J Biol Chem       Date:  1960-06       Impact factor: 5.157

4.  The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors:  R H SILBER; C C PORTER
Journal:  J Biol Chem       Date:  1954-10       Impact factor: 5.157

5.  Effect of aminoglutethimide on urinary steroid excretion in patients with congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency.

Authors:  K Horký; O Kuchel; I Gregorová; L Stárka
Journal:  Metabolism       Date:  1972-04       Impact factor: 8.694

6.  [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].

Authors:  M Philbert; M H Laudat; P Laudat; H Bricaire
Journal:  Ann Endocrinol (Paris)       Date:  1968 Mar-Apr       Impact factor: 2.478

7.  Effects of amino-glutethimide on adrenal function in man.

Authors:  L M Fishman; G W Liddle; D P Island; N Fleischer; O Küchel
Journal:  J Clin Endocrinol Metab       Date:  1967-04       Impact factor: 5.958

8.  Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

Authors:  R Cash; A J Brough; M N Cohen; P S Satoh
Journal:  J Clin Endocrinol Metab       Date:  1967-09       Impact factor: 5.958

9.  Suppression of tumorous adrenal hyperfunction by aminoglutethimide.

Authors:  R P Smilo; J M Earll; P H Forsham
Journal:  Metabolism       Date:  1967-04       Impact factor: 8.694

10.  Nonpituitary neoplasms and Cushing's syndrome. Ectopic "adrenocorticotropin" produced by nonpituitary neoplasms as a cause of Cushing's syndrome.

Authors:  G W LIDDLE; D P ISLAND; R L NEY; W E NICHOLSON; N SHIMIZU
Journal:  Arch Intern Med       Date:  1963-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.